Similar articles for PMID: 19443679

Year	Number of Results
1996	1
1998	1
2001	3
2003	2
2004	4
2005	9
2006	6
2007	7
2008	19
2009	8
2010	11
2011	8
2012	2
2013	7
2014	6
2015	3
2017	1
2021	4
2024	0

1

The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.

Meaney A, Ceballos G, Asbun J, Solache G, Mendoza E, Vela A, Meaney E. Meaney A, et al. J Clin Pharmacol. 2009 Jul;49(7):838-47. doi: 10.1177/0091270009337011. Epub 2009 May 14. J Clin Pharmacol. 2009. PMID: 19443679 Clinical Trial.

2

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators. Kastelein JJ, et al. N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376000 Free article. Clinical Trial.

3

Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D. Avellone G, et al. Int Angiol. 2010 Dec;29(6):514-24. Int Angiol. 2010. PMID: 21173733 Clinical Trial.

4

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M. Taylor AJ, et al. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15. N Engl J Med. 2009. PMID: 19915217 Free article. Clinical Trial.

5

Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.

Kastelein JJ, Sager PT, de Groot E, Veltri E. Kastelein JJ, et al. Am Heart J. 2005 Feb;149(2):234-9. doi: 10.1016/j.ahj.2004.06.024. Am Heart J. 2005. PMID: 15846260

6

The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.

Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A. Efrati S, et al. Eur J Clin Pharmacol. 2007 Feb;63(2):113-21. doi: 10.1007/s00228-006-0238-4. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200833 Clinical Trial.

7

The Vytorin on Carotid-Media Thickness and Overall Arterial Rigidity (VYCTOR) study.

Farmer J. Farmer J. Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1057-60. doi: 10.1586/erc.09.97. Expert Rev Cardiovasc Ther. 2009. PMID: 19764858

8

The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study.

Duman D, Demirtunc R, Sahin S, Esertas K. Duman D, et al. J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):1007-11. doi: 10.2459/JCM.0b013e3282f03bc1. J Cardiovasc Med (Hagerstown). 2007. PMID: 18163011 Clinical Trial.

9

Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.

Smith D. Smith D. Mt Sinai J Med. 2008 Mar-Apr;75(2):143-7. doi: 10.1002/msj.20031. Mt Sinai J Med. 2008. PMID: 18500716 No abstract available.

10

Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.

Toutouzas P, Richter D. Toutouzas P, et al. Angiology. 2008 Apr-May;59(2 Suppl):77S-9S. doi: 10.1177/0003319708321748. Epub 2008 Jul 15. Angiology. 2008. PMID: 18628278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year